Are DaliRasen tablets expensive? Analysis of cost performance and medical insurance coverage

Daridorexant is a new type of drug mainly used to treat insomnia. It is a dual receptor antagonist that helps improve patients' ability to fall asleep and maintain sleep by regulating neurotransmitters in the brain. Compared with traditional sleep-aid drugs, Dalilaysan has shown better effects in reducing daytime sleepiness and improving sleep quality, so it has received widespread attention.

Currently, DaliRasen has not yet been launched in the Chinese market, which means that domestic patients cannot directly purchase the drug. For patients who need to use the drug, they usually need to purchase it through overseas channels. In foreign markets, especially in Europe, the original drug of Dalilaysan has been launched. The common specification is 50mg*30 tablets, and the price is about more than 2,000 yuan. This price may change due to exchange rate fluctuations, but overall, it does appear to be more expensive than many other commonly used drugs.

In terms of cost-effectiveness, although the price of DaliRasen is relatively high, its efficacy and safety give it certain advantages in the treatment of insomnia. When patients use DaliRasen, they can not only fall asleep faster, but also improve the overall quality of sleep and reduce daytime fatigue. This is of great significance to modern people with high workloads and high pressure in life. Additionally, due to the impact insomnia has on physical health and quality of life, many patients are willing to pay more for better sleep quality.

However, the medical insurance coverage of DaliRasen is currently unclear because it has not yet been launched in the country. The specific medical insurance policy and coverage still need to wait for the evaluation and decision of the relevant departments. If DaliRasen is approved for marketing in the future and entered into the medical insurance catalog, it will further reduce the financial burden on patients, improve its accessibility, and promote wider clinical application.

Reference materials:https://www.quviviq.com/